Skip to main content
. Author manuscript; available in PMC: 2015 Mar 10.
Published in final edited form as: Am J Med Genet C Semin Med Genet. 2014 Mar 10;166(1):68–75. doi: 10.1002/ajmg.c.31385

Table 2.

Most common medications in active participants

Medication Frequency, n (%) Genes Reported
Aspirin 213 (26%) LTC4S
Hydrochlorothiazide 169 (21%) REN, ADD1
Atorvastatin 138 (17%) SLCO1B1, GNB3, KIF6
Lisinopril 118 (15%) none
Amlodipine 111 (14%) CYP3A4, CACNA1C
Metoprolol 104 (13%) ADRB1, GRK4
Levothyroxine 91 (11%) none
Simvastatin 69 (8%) SLCO1B1, ABCB1
Omeprazole 65 (8%) CYP2C19
Atenolol 55 (7%) LDLR, GNB3, AGT
Losartan 52 (6%) none
Furosemide 46 (6%) none
Warfarin 45 (6%) CYP2C9, VKORC1
Esomeprazole 44 (5%) none
Metformin 44 (5%) none
Prednisone 43 (5%) none
Fluticasone propionate 40 (5%) none